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AMILCAR CHALLU and MANUEL MART1NEZ-MALDONADO
Committee on Nephrology Development and National Problems of the Latin American Society of Nephrology and Hypertension
(SLANT!)
Latin American nephrology is undergoing major changes as the
study of kidney diseases is being transformed into a global
discipline, propelled by rapid communication, numerous trans-
portation systems and the subsequent sharing of knowledge.
The term "Latin America" refers to the 20 countries in the
Western Hemisphere where the predominant spoken language
derives from Latin, in this case, Spanish and Portuguese. The
countries are in North America (Mexico), Central or Mezzo-
America (Costa Rica, El Salvador, Guatemala, Honduras, Nica-
ragua, and Panama), South America (Argentina, Bolivia, Brazil,
Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay and Vene-
zuela), and in the Caribbean (Cuba, Dominican Republic, and
Puerto Rico). Note that French (another romance language) is
spoken in Haiti, Guadaloupe and Martinique; however, these
island countries have not participated in SLANH meetings thus
far. All these Countries are republics, except Puerto Rico, which is
a commonwealth of the United States. Puerto Ricans are Amer-
ican citizens by birth, and the laws of the country are a combina-
tion of the federal laws applicable to any state of the Union and
local laws developed by an autonomous legislature. All the
countries have Spanish as their common language, except Brazil
where Portuguese is spoken.
Latin America encompasses an enormous geographic area full
of dramatic contrasts, cultural differences and economic inequal-
ities. Not only do huge distances separate countries, but large
uninhabited territories coexist with densely populated metropol-
itan areas. There are sylvan or mountainous regions where
indigenous inhabitants still exist under primitive conditions, and
stark social imbalances are palpable in urban areas where extreme
wealth and misery rub elbows. Moreover, governmental infra-
structures are frequently deficient, and inefficient data gathering
limits access to complete information on which to base accurate
analyses of demographic information [l—7J. In spite of these
hurdles, over the years Latin American countries have come
closer together as political reform and economic needs have
accentuated the common roots and traditions that unite the
members of this community. The ancestral indigenous cultures
and the acquired Euroculture have brought under two fundamen-
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tal influences—religion and folklore—the idiosyncratic, but laudable
features that are hospitality, tolerance and respect for ethnic
differences.
In preparing this article, we have relied heavily upon interna-
tional sources whose assessment mechanisms are frequently un-
clear; consequently we have been careful in data interpretation.
Information gaps exist in various areas that were of particular
interest to us [8, 91, for example Cuba, which represents a singular
Latin American experience in the nephrology context, and about
which we do not have international data comparable to that used
from other countries.
In broad strokes this article provides a picture of the state of
nephrology in Latin America, points to some of our concerns, and
indicates some of the initiatives that the Latin American Society
of Nephrology and Hypertension (in Spanish, SLANH) has
embarked upon on behalf of nephrology [10—12]. We have also
sought to identify factors that may influence the development of
nephrology in Latin America.
PRESENT STATE OF NEPHROLOGY IN LATIN AMERICA
Factors influencing nephrological development
Nephrolo Societies. The Argentinean and Brazilian Nephro-
logical Associations were established in 1960, coinciding with the
founding of the International Society of Nephrology. Thus, the
largest and most populated countries of the South American
continent responded relatively quickly to the development of
nephrology elsewhere in the world.
The Latin American Society of Nephrology was founded in
COrdoba, Argentina in 1970 (it was renamed Latin American
Society of Nephrology and Hypertension in its 9th Congress in
San Juan, Puerto Rico in 1994) and unites Latin American
countries in one common society. In addition, SLANH claims as
members Latin Americans residing in the United States who over
the years have become major human and scientific resources, and
have provided particular strength to the Society. SLANH has as
its primary goal the unification into one society of all individuals
of Latin American origin who practice nephrology in or outside
Latin America (as defined above) in order to contribute to the
dissemination of knowledge in the clinical and investigative
aspects of the specialty in Latin America. In addition, SLANH
promotes excellence in nephrological training and establishes
courses of continuing medical education for nephrologists and
health related nephrological specialists such as nurses, technicians
and social workers. It also seeks to establish relationships with
other nephrology societies with which it shares similar scientific
and clinical pursuits, and which have a specified interest in the
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NA is not available.
Table 1. Latin American nephrology demographics, 1995_1996a
a Adapted from Vaamonde [20]
"Source: The World Almanac 1996. World Almanac, Books, Mahwah, 1996
Information provided to SLANH by National Societies (provided between 3/96—5/96)
cl PMP, per million people
Percent of total physicians who are nephrologists
Cuban data regarding nephrologists is from 1996 data; data regarding population & physicians from 1993
5American Medical Association. Physician characteristics and distribution in the US. 1995/1996 edition, AMA, Chicago
American Society of Nephrology, Member resource directory 1995—1996, Williams and Wilkins, Baltimore, MD
Dr. Fernando Valderrabano, personal communication to Carlos Vaamonde, M.D., May 1996
'Per 1000 live births (data 1994)
Average of all countries
development of the region. Most of these goals set by the founders
of the society have been achieved as suggested by a total mem-
bership of 3738, including 55 Latin Americans in the United
States [131. The American Society of Nephrology has close to 5000
members, but includes in its membership Ph.D. and other scien-
tists who have published "at least one creditable paper in the field
of nephrology" [141. SLANH has recently begun an initiative to
adopt these criteria for its own membership. During the period of
its existence SLANH has held ten congresses in major Latin
American cities (Córdoba, Mexico City, Bogota, Havana, Caracas,
Buenos Aires, Lima, RIo de Janciro, Quito, San Juan and
Santiago de Chile) with attendances ranging from several hundred
to over 1500. SLANH has also promoted and participated in
dozens of courses, congresses, national and international meet-
ings in all aspects of nephrology and hypertension throughout
Central and South America and the Caribbean. Strong ties have
been developed between SLANH and the Spanish and Portu-
guese Societies of Nephrology, with whom it celebrates Ibero-
American Congresses of Nephrology, the third of which took
place in Lisbon in March 1997. In addition, the American Society
of Nephrology is holding conversations with SLANH leadership
to formalize closer ties that were begun with ASN traveling grants
provided to young SLANH members to attend the ASN annual
meeting in Orlando in 1992. Moreover, the president of SLANH
is a member of the Latin American subcommittee of the Interna-
tional Society of Nephrology committee on global development of
nephrology. Furthermore, the SLANH and ISN will have a joint
meeting in 1999 in Buenos Aires, Argentina, the second meeting
ever of two international nephrology societies since the creation
of nephrology societies in the 60s and 70s. Finally, SLANH now
publishes its own scientific quarterly, Nefrologia Latinoamericana,
and the first dialysis and transplant registry from the region.
SLANH has recently set out to establish long-term programmatic
activities to identify problems relating to the nature and practice
of nephrology in the member countries.
Number of nephrologists, dialysis nurses and technicians
During the sixties and seventies there was an influx of nephrol-
ogists to Latin America who had been trained in the United States
and Europe. From 1979 to 1996 all countries in the region
experienced a dramatic increase in the number of nephrologists,
and in that period SLANH grew from 1001 to 3738 members! The
data in Table 1 present a series of revealing facts and important
pitfalls. It seems clear that for a population that is 45% larger than
Country
Area km2
x 1000 Population
(1994)" x 1000"
GNP
($US
million)
1992"
Infant
mortality
rate
1992'
Women
Physicians" Nephrologists" nephrologistsc
Physicians Nephrologists Percent
—_PMP" PMPd nephrologists"
Argentina 2767 34,293 200282 29 105,192 731 223 3067 21.3 0.69
Bolivia 1099 7,896 5084 82 3,083 40 8 390 5.1 1.3
Brazil 8512 160,737 425412 57 189,549 1,582 602 1179 9.8 0.83
Chile 757 14,161 37064 17 15,929 105 14 1125 7.4 0.66
Colombia 1139 26,200 44555 37 33,581 69 5 928 1.9 0.21
Costa Rica 51 3,419 6261 14 3,554 15 1 1039 4.4 0.42
Cuba' 110.8 10,938 NA 11 47,349 237 71 4329 21.7 0.5
Dominican Republic 49 7,948 7611 53 8,510 35 11 1071 4.4 0.41
Ecuador 284 10,891 11843 53 13,027 34 3 1196 3.1 0.26
El Salvador 21 5,870 6283 46 2,761 14 0 470 2.4 0.51
Guatemala 109 10,999 9568 58 4,337 19 3 394 1.7 0.44
Honduras 112 5,460 3142 49 3,442 7 0 630 1.3 0.2
Mexico 1958 93,986 294831 35 106,199 201 29 1130 2.1 0.19
Nicaragua 130 4,206 1325 53 2,235 11 2 531 2.6 0.49
Panama 76 2,681 6133 21 3,176 16 5 1185 6 0.5
Paraguay 407 5,358 6038 47 3,765 26 10 703 4.9 0.69
Peru 1285 24,087 21272 52 24,160 118 20 1003 4.9 0.49
Puerto Rico 9 3,691 23603 14 8,445 48 7 2288 13 0.57
Uruguay 177 3,223 10444 20 10,924 117 75 3389 36.3 1.07
Venezuela 912 21,005 58901 33 36,467 257 76 1736 12.2 0.7
Total 133,616.80 467,049 1,179,652 39" 625,685 3,682 1,165 1389" 83k 056k
Canada 9922 28,435 5371000 7 63,988 227 30 2250 8 0.35
United States 9809 258,932 5904822 9 684,414 4,624" 598 2643 17.9 0.68
Spain 5047 39,404 514900 7 153,324 805' NA 3891 20.4 0.53
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Table 2. Listing and evaluation of nephrological resources
that of the United States, Latin America has only 46% the number
of nephrologists per million people (PMP) [15, 16]. This could be
the result of a difference of 53% in the number of physicians PMP
between the U.S. and Latin America. A low number of physicians
can lead to erroneous interpretation of the meaning of the
percent of physicians who are nephrologists in each country.
Bolivia, for example, has twice as many nephrologists PMP as the
U.S., but it also has the second lowest number of physicians PMP
in the region. Except for Argentina, Brazil, Uruguay and Vene-
zuela, all countries have lower percentages of nephrologists out of
the total population of physicians than the U.S. In contrast, eleven
countries with at least 35% of the physicians PMP in the U.S. have
greater numbers of nephrologists per physician than Canada;
three of those countries also surpass the numbers for Spain. The
fact remains that Latin America has only 8.3 nephrologists PMP
compared to 17.9 in the U.S.
Table I also indicates that compared to Puerto Rico, the Latin
American country that most closely parallels the U.S., there is a
need for technicians and nurses (analyzed together because they
perform similar duties in most of these countries) in most
countries. Argentina and Uruguay are the only countries with
numbers approaching those of Puerto Rico.
Renal replacement resources
The first hemodialysis therapy was carried out in Argentina in
1955 (10 years after the first one in the world), and the first kidney
transplant was performed there in 1957 (3 years after the first in
the world). Nevertheless, despite a significant growth in the
delivery of nephrological services throughout Latin America, in
general, dialysis and transplantation have lagged behind the rate
of dialysis in most developed countries around the world. As
shown in Table 2, Bolivia (one of the poorest countries) with a
population of over 8 million inhabitants has only 79 patients on
hemodialysis; Argentina (one of the richest countries) has a
population that represents 13% of the population of U.S., yet it
only has 6% the U.S. number of dialysis patients. Brazil with over
161 million inhabitants or —60% the population of USA only has
9% of patients on dialysis as compared to the U.S.
There are —750 hemodialysis patients per million (PMP) in the
United States. By contrast, Latin America has currently 34,977
(Table 2) recorded hemodialysis patients for 462 million people, a
rate of 76 patients PMP, about one tenth that of the U.S. The
highest number of dialysis patients PMP in Latin America is
Puerto Rico, where the Medicare laws for the management of
end-stage renal disease (ESRD) apply [17].
In the United States peritoneal dialysis (CAPD/CCPD) ac-
counts for one third of all end-stage renal disease therapy [18]. It
should be clear from Table 2 that peritoncal dialysis represents
slightly over 50% of all patients receiving a form of dialysis
treatment. The reader should be aware that a large number of
these patients actually receive intermittent acute dialysis rather
than CAPD or CCPD.
Compared to the 71,000 transplants performed in the U.S.
between 1983 and 1991, in Latin America between 1956 and the
Technical HD Centers Number
Peritoneal Renal & Technicians Hemodialysis centers per of Beds Score of
Hemodialysis dialysis transplant Total/ nursing per Technicians centers PMP 1000 dialysis per nephrological
Country patients patients patients PMP staff nephrologists PMP" [19] [19] km2 beds Center resourcest
Argentina 9000 100 NA" 271.7k' 1800 4.5 52.53 409 12.5 0.13 1420 3.47 4.0
Bolivia 79 55 NA" 168h, 21 0.88 2.6 15 1.94 0.01 28 1.87 1.33
Brasil 15000 5200 3600 162 NA NA NA 371 2.37 0.04 400 8.09 2.33
Chile 2962 9 NA" 215.11 NA NA NA 77 5.66 0.1 342 4.44 2.67
Colombia 756 572 NA" 38.1'" 158 2.63 4.5 38 1.17 0.03 14 3.42 1.33
Costa Rica 75 33 284 121.4 12 0.63 3.5 54 1.30 0.08 22 0.41 2.0
Cuba 477 225 567 116.3 150 1.14 13.73 27 2.54 NA 106 3.93 3.0
Dom. Rep. NA NA 23 28.2" 20 0.74 2.53 11 1.55 0.22 21 1.91 1.33
Ecuador 305 50 NA" 31.2" 6 0.87 2.51 17 1.62 0.06 49 2.88 1.33
El Salvador 83 46 13 25.1 20 2 3.47 8 1.48 0.38 20 2.5 1.33
Guatemala NA NA NA" NA 30 1.67 2.82 8 1.13 (1.07 50 6.25 1.0
Honduras 50 60 18 22.7 NA NA NA 21 0.38 0.02 NA NA 1.33
Mexico 1200 12000 NA 140.1" 150 1.14 1.6 66 0.71 0.03 150 2.27 2.0
Nicaragua NA NA NA" NA NA NA NA NA NA NA NA NA NA
Panama 110 8 10 50 11 0.79 4.14 7 2.79 0.09 43 6.14 2.0
Paraguay
Peru
300
1528
0
29
70
NA"
79.7
549c
14
331
0.93
2.76
2.86
13.88
10
29
2.21
1.24
0.02
0.02
22
112
2.2
3.86
2.0
2.33
Puerto 1967 388 NA" 610.1" 300 5.45 81.28 24 6.82 2.67 297 12.38 4.0
Rico
Uruguay 1338 51 180" 498.1 172 1.26 53.99 29 9.15 0.16 141 4.86 4.0
Venezuela 1628 725 408 130.1 300 1.64 13.96 60 2.90 0.07 350 5.83 3.0
"Per million people
"Without transplant figures
"Dialysis figures from 1992
"Dialysis figures from 1991
"Incomplete information regarding transplants
Nephrological score was calculated assigning values from 4 (best) to ito these items: patients receiving replacement therapy (column 4), technicians
(column 7), and HD centers (column 9)—all PMP. Four groups emerge: Argentina, Puerto Rico & Uruguay have the highest score (4). Brazil, Chile,
Cuba & Venezuela form a high median group; a low median group is formed by Costa Rica, Mexico, Panama, Paraguay, and Peru. The remainder form
the low group.
NA, not available.
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end of 1993 there were only 17,119 transplants. This may be an
underestimate since the number was compiled from data provided
voluntarily by countries to the SLANH dialysis and transplant
registry. Nevertheless, the rate of transplantation is subordinate to
the available resources in most countries.
The foregoing reveals that most renal patients in Latin America
die without receiving replacement therapy. Using a calculation of
400 patients PMP (the number is 732 PMP in the U.S. for 1991)
the conservative estimated prevalence of patients needing dialytic
treatment in Latin America would represent a total of approxi-
mately 187,000 patients. Only 61,400 patients received hemodial-
ysis, peritoneal dialysis or transplantation in 1993, leaving 126,000
who did not receive any form of renal replacement therapy.
Frequency of renal disease
Precise numbers on incidence and prevalence of renal diseases
are not available for all countries. The frequency of renal disease
for 1993 [161 shows that the most frequent nephropathies were
diabetes mellitus, hypertensive nephropathy, ADPKD, tubuloin-
terstitial nephropathy, obstructive nephropathy, lupus nephritis,
amyloidosis, multiple myeloma, and an undetermined cause was
cited in as many as 15.6%. Hypertensive nephrosclerosis ac-
counted for 20.9% and diabetes mellitus for 16.9% of all cases of
chronic renal failure in Latin America [4]. It is of interest that as
a cause of chronic renal failure diabetes mellitus ranged from 11%
in El Salvador to 51.2% in Puerto Rico. The reasons for this wide
spectrum is not clear, but it is likely that many patients with
diabetes succumb to acidosis, infections, vascular or other diseases
before developing renal insufficiency.
Economic resources
With few exceptions, the health authorities of most Latin
American countries view nephrology as the subspecialty of dialysis
procedures and kidney transplantation, practices that require an
economic infrastructure capable of affording the expenditures
these procedures entail. The cost of dialysis and transplantation
programs are far beyond the present fiscal capabilities of most
Latin American governments already faced with double digit
annual inflation rates and huge external debts [8J. In some
countries the expenditures for dialysis alone would exceed 50% of
their gross national product [91.
The high cost of dialysis, let alone transplantation, frequently
clashes with the economic realities of each country. General
health is frequently poor and this situation requires that these
countries spend their limited resources on more urgent and
immediate needs rather than on high technological procedures.
Faced with high rates of poverty and illiteracy, both of which
increase the mortality of children and infants and perinatal death
of women, it is unlikely that any socially conscious government
would assign a large portion of scarce resources to treat a few
patients. In fact, we have calculated that hemodialysis costs to
treat 600 patients per million would exceed the economic capa-
bility (GNP) of at least one country.
General health conditions of Latin America
There is a preponderance of communicable diseases in most of
the Latin American countries compared to the incidence of
chronic non-communicable diseases. Infectious (non-HIV) dis-
eases, including parasitic diseases, still constitute a scourge over
their inhabitants [2—4, 6—9]. In addition, inadequate perinatal
care as a result of poor access to health programs, customs and
religious beliefs contribute to high maternal-infant mortality, a
problem of high international visibility and, thus, a greater
political impact and priority. Malnutrition still taxes the health
resources in the area, and the need for the development of
sanitary facilities is patently clear. Equally problematic are basic
immunization programs and control of viral diseases such as those
transmitted by the hepatitis viruses.
Politics and general health policy in the region
Latin America as a region has suffered from chronic political
instability, frequent institutional breakdowns, and inflationary
problems, all circumstances that preclude reliable health policies
and an adequate allocation of resources. These conditions were
particularly prevalent in the sixties, which witnessed the birth of
nephrology.
The nineties are a turning point: the trends that began in the
eighties are becoming the general policies of the area. With few
exceptions, there has been consolidation of democratic forms of
government and a straightforward economic opening to world
markets. The model of a market society has been adopted—
admittedly, to different extents—by all the countries, in harmony
with world economic globalization. The main features of this
decade are: (1) return to democratic forms of governing; (2)
opening to national and international market economies; (3)
establishment of regional economic agreements; (4) a movement
toward financial recuperation; (5) state reorganization; and (6)
privatization of public utilities and national corporations. As a
result of these important changes, a number of improvements
have been made that may ultimately contribute to better general
health in the region. These include reduction of inflation, which is
at least partly a product of the re-negotiation of the external debt
and reduction of the public deficit as well as greater external
investment. Most importantly, there has been significant state
reorganization under more democratic structures.
It is heartening to note that these changes already have had
some effect on nephrological development. In the past decade it
has been possible to make inroads in the arduous business of
having the governments of the region heed advice from interested
parties in relation to renal diseases.
Dialysis policy
Countries such as Argentina, Brazil, Chile, Mexico and Uru-
guay have some form of policy for health insurance coverage for
the patient in end-stage renal disease [8, 9]. These countries do
not have laws comparable to the Medicare program for ESRD in
the United States—of which Puerto Rico is the sole beneficiary—
however, they are at the top of the economic developmental
ladder in the area. Table 3 summarizes the information available
from those countries where some form of law exists to cover renal
therapy. Not surprisingly, the countries with the largest GNPs
provide the best coverage for the renal patient and, generally
speaking, include both dialysis and transplantation. Brazil, Chile
and Uruguay provide insurance coverage for most of their pa-
tients. Venezuela, Argentina, Bolivia, Mexico and Peru provide
coverage to from 10 to 60% of renal patients through their own
form of social security. Spotty if not erratic coverage mostly for
peritoneal dialysis and for limited hemodialysis is offered in El
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Table 3. Laws concerning ESRD patients and resources covering expenditures
Dialysis Transplantation Blood Bank Patients have Covered by
Country laws laws laws legal aid government
Argentina yes, 1985 yes, 1978 yes yes 10%
Brazil yes yes, 1966 NA NA significant"
number
yes yes the majority
NA NA NA
yes no significanta
number
NA NA
no no
no no
yes yes
no
Venezuela no yes, 1992 NA no
NA, information not available.
Figures vary according to budgetary changes, inflation, etc.
"Same as USA
Salvador, Dominican Republic and Panama. Clearly, governmen-
tal supported programs make a major difference in the affordabil-
ity of hemodialysis programs. An adequate hemodialysis program
cannot emerge in the presence of fiscal chaos, a situation that
exists far too frequently in many Latin American countries, often
as result of political uncertainty and social unrest.
Nephrology as a detection and prevention subspecialty
We have already pointed Out that often the monetary resources
needed for nephrological technology are above the gross national
product of some countries. We feel that participation in detection
and prevention in the chronic disease programs of health minis-
tries, and the formation of alliances with public health workers,
may be a way to convince governments that nephrologists in Latin
America are interested in approaches other than technology-
supported treatment. Two conditions that are particularly critical
to identi' for potential prevention of renal disease are hyperten-
sion and diabetes mellitus. As health and economic conditions
evolve in each country, an adequate coverage policy for those with
ESRD could be developed that would allow greater nephrological
development. It appears to us that multinational corporations,
whose business includes dialysis procedures, should he called
upon by governmental agencies and nephrological groups, includ-
ing national societies of nephrology, to help develop economically
feasible programs. It is reasonable to expect that adequate
remuneration of nephrological services, particularly in the area of
detection and prevention, could be an incentive to attract medical
students to nephrology. Careful analysis of the local needs for
nephrological expertise could also lead to improved planning of
curricula in the discipline, and the inclusion of epidemiology and
public health practices as they relate to detection and prevention.
PROSPECTS FOR DEVELOPMENT
The possibilities of developing opportunities for patients to
have access to dialysis treatment upon reaching end-stage renal
disease represent an ethical imperative [101 that must be the
responsibility of every party involved in the care of the patient
with kidney disease. Since we have considered an adequate
dialysis policy as the main factor, Latin American national soci-
Covered by
Covered by private Covered by
Social Security institutions patient
90%
significant significant significant
number number number
NA NA NA
significant significant some
number number
NA NA NA
yes NA NA
only workers NA NA
100%
eties of nephrology must take a leading role in the development of
sound principles of treatment and resource allocation through
which implementation can be pursued equitably and judiciously.
In addition, nephrology societies should be ready to present
information to governmental agencies, to organize awareness
campaigns addressed to the lay and scientific community and,
particularly, to the community of renal patients. The Latin
American Society of Nephrology and Hypertension (SLANH)
already plays a counseling role, supported by its scientific exper-
tise, and has embarked on a concerted effort to organize regional
meetings to exchange information about the existing models of
legislation related to coverage and fees for the renal patient.
SLANH is particularly worried with the future of nephrology
training for Latin Americans. Changes in the number of fellow-
ship offerings by programs in the U.S. in the years to come will
limit access of all international graduates to U.S. training pro-
grams. Training programs in Latin America must he developed
and those already in existence strengthened. These training
programs should be based on the tenets that fundamental knowl-
edge of internal medicine or pediatrics is necessary before spe-
cialization. Knowledge of public health and epidemiology as well
as the basic sciences should be part of the curriculum if the
graduates of these programs are to remain competitive within the
field.
The international nephrological community must play an essen-
tial role in counseling governments on the most suitable technol-
ogy for the particular situations of each country. The recently
formed TSN Council on Global Development of Nephrology as
well as committees of SLANH have begun a series of visits to
countries in which education of political leaders may change the
image of nephrology as more than a "dialysis and transplantation"
specialty. The academic training of nephrology specialists in Latin
America seems to be encouraged by these visits. In fact, the
organization of regional scientific meetings with the presence of
internationally known specialists has made a major impact in the
area. In the past decade there has been a rapid growth of scientific
meetings sponsored by ISN and SLANH; moreover, the develop-
ment of relationships with the Spanish and Portugese Nephrology
Societies and the initiation of Ibero-American Congresses has
Chile
Honduras
Mexico
Panama
Paraguay
Peru
Puerto Rico
Uruguay
no
NA
no
NA
no
no
b
yes, 1980
yes, 1982
yes, 1954
yes, 1984
yes, t983
no(21)
yes, 1974
yes, 1971
yes, 1971
NA
no
yes
b
yes, 1979 treatment is
compulsory
60% 40%
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widened the contact of Latin American nephrologists with their
international peers. These activities have already been fruitful,
and have produced training programs such as apprenticeships,
fellowships, scientific exchanges, etc.
We suggest that scientific societies must review their almost
exclusively academic missions and, without surrendering their
primary scientific purposes, objectively analyze the teaching,
learning, and practice of nephrology, particularly as these relate to
detection and prevention of renal disease. They must properly
examine, within the context of individual countries, the need and
feasibility of developing dialysis and transplantation as treatments
of end-stage renal disease in the regions of the world where
presently these modalities are not optimal.
Reprint requests to Manuel MartInez-Maldonado, MD., Department of
Medicine (111), Atlanta Veterans Affairs Medical Center, 1670 Clairmont
Rd., Decatur, Georgia 30033, USA.
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